Roundhill GLP-1與減肥主動型ETF OZEM 深 滬
等待開盤 04-10 09:30:00 美东时间
31.90
+0.202
+0.64%
華盛通- 最 高31.9999
- 今 開31.62
- 成交量 6092股
- 最 低 31.4401
- 昨 收 31.6977
- 總市值 5295.40万
- 52周最高 37.15
- 市盈率 靜 --
- 換手率 0.37%
- 52周最低 22.2301
- 委 比 17.50%
- 總股本 166.00万
- 歷史最高 37.15
- 量 比 0.44
- 振 幅 1.77%
- 歷史最低 19.6001
- 每 手 1
- 風險率 4.42%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BRIEF-Hims & Hers Says We Will Expand Our Platform To Include Wegovy® Pills And Injections And Ozempic® Injections
BRIEF-Hims & Hers Says We Will Expand Our Platform To Include Wegovy® Pills And Injections And Ozempic® Injections March 18 (Reuters) - Hims & Hers Health Inc HIMS.N : HIMS & HERS: WE WILL EXPAND OUR PLATFORM TO INCLUDE WEGOVY® PILLS AND INJECTIONS AND OZEMPIC® INJECTIONS HIMS & HERS HEALTH INC - WE
03-18 20:51
Here are the quant ratings of OZEM’s top holdings amid Novo's selloff
The Roundhill GLP-1 & Weight Loss ETF (OZEM) came into focus on Monday after Novo Nordisk (NVO) shares tumbled as the firm's next-generation obesity drug CagriSema delivered less weight loss than Eli ...
02-24 02:06
OZEM stock: What the Ratings say
The Roundhill GLP-1 & Weight Loss ETF (OZEM) came into focus on Monday after Novo Nordisk (NVO) shares tumbled as the firm's next-generation obesity drug CagriSema delivered less weight loss than Eli ...
02-23 23:38
BRIEF-Meijer Announces New Affordable Access To GLP-1 Medications
BRIEF-Meijer Announces New Affordable Access To GLP-1 Medications Feb 10 (Reuters) - Meijer Inc [RIC:RIC:MEIJR.UL]: MEIJER ANNOUNCES NEW AFFORDABLE ACCESS TO GLP-1 MEDICATIONS MEIJER INC - WEGOVY OR OZEMPIC INJECTION PENS FOR $199 PER MONTH FOR FIRST TWO MONTHS MEIJER INC: ELIGIBLE PATIENTS CAN ACCE
02-10 22:39
EXCLUSIVE: Trump 'Amplified' Several Investing Themes – ETF CEO Picks 3 Sectors Benefitting The Most
President Donald Trump may be creating investment opportunities in themes and helping put an emphasize thematic ETFs.
01-28 06:05
Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk
Novo's trial setback tests GLP-1-heavy ETFs, highlighting concentration risks while Eli Lilly's diversified pipeline offers relative resilience.
2025-11-25 01:06
华盛早报 | 外资又来唱多！大摩称中国股市有望继续上涨；美联储12月降息概率再降至43%
外资又来唱多！大摩称中国股市有望继续上涨；美联储12月降息概率一降再降，现已接近40%；拼多多、小米集团今日发财报>>
2025-11-18 08:23
BRIEF-Novo Nordisk Launches Introductory Self-Pay Offer For Wegovy And Ozempic For $199 Per Month
Nov 17 (Reuters) - Novo Nordisk A/S NOVOb.CO: NOVO NORDISK LAUNCHES INTRODUCTORY SELF-PAY OFFER FOR WEGOVY® AND OZEMPIC® FOR $199 PER MONTH NOVO NORDISK - LOWERING PRICE OF WEGOVY(®) AND OZEMPIC(®) FO...
2025-11-17 20:50
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain
As Eli Lilly, Novo Nordisk, and Pfizer battle for dominance in the obesity-drug market, these ETFs are offering exposure to the GLP-1 gold rush.
2025-10-31 04:04
CORRECTED-EXCLUSIVE-Novo Nordisk cuts hit production line jobs at key US plant, posts show
In paragraph 8, removes reference to the layoff of a strategic communications manager Novo Nordisk lays off staff at Clayton, NC plant, posts show Clayton site crucial for Wegovy production, U.S. expa...
2025-10-07 13:00
